Trimethoprim and Staring - a phase IV clinical study of FDA data
Staring is found among people who take Trimethoprim, especially for people who are female, 30-39 old.
The phase IV clinical study analyzes which people take Trimethoprim and have Staring. It is created by eHealthMe based on reports of 4,574 people who have side effects when taking Trimethoprim from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
4,574 people reported to have side effects when taking Trimethoprim.
Among them, 9 people (0.2%) have Staring.
What is Trimethoprim?
Trimethoprim has active ingredients of trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 4,887 Trimethoprim users for its effectiveness, alternative drugs and more.
What is Staring?
Staring (a prolonged gaze or fixed look) is found to be associated with 792 drugs and 483 conditions by eHealthMe.
Number of Trimethoprim and Staring reports submitted per year:
Gender of people who have Staring when taking Trimethoprim *:
- female: 100 %
- male: 0.0 %
Age of people who have Staring when taking Trimethoprim *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 75 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 25 %
Common drugs people take besides Trimethoprim *:
- Sertraline: 5 people, 55.56%
- Zocor: 2 people, 22.22%
- Trental: 2 people, 22.22%
- Prilosec: 2 people, 22.22%
- Lisinopril: 2 people, 22.22%
- Lanoxin: 2 people, 22.22%
- Klonopin: 2 people, 22.22%
- Fentanyl: 2 people, 22.22%
- Coumadin: 2 people, 22.22%
- Clonidine: 2 people, 22.22%
Common side effects people have besides Staring *:
- Drowsiness: 9 people, 100.00%
- Yawning (simultaneous inhalation of air and stretching of the eardrums, followed by exhalation of breath): 7 people, 77.78%
- Logorrhea: 7 people, 77.78%
- Decreased Eye Contact: 7 people, 77.78%
- Diarrhea: 7 people, 77.78%
- Disturbance In Attention: 7 people, 77.78%
- Dizziness: 7 people, 77.78%
- Drug Ineffective: 7 people, 77.78%
- Dysphemia (stammering or stuttering): 7 people, 77.78%
- Fear: 7 people, 77.78%
Common conditions people have *:
- Stress And Anxiety: 7 people, 77.78%
- Back Pain: 2 people, 22.22%
- Gait Disturbance: 1 person, 11.11%
- Dysphemia (stammering or stuttering): 1 person, 11.11%
- Dizziness: 1 person, 11.11%
* Approximation only. Some reports may have incomplete information.
Do you take Trimethoprim and have Staring?Check whether Staring is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Trimethoprim:
- Trimethoprim (4,887 reports)
Staring treatments and more:
- Staring (2,798 reports)
COVID vaccines that are related to Staring:
- Staring in Moderna COVID Vaccine
- Staring in Pfizer BioNTech Covid Vaccine
- Staring in Johnson and Johnson Covid Vaccine
How severe was Staring and when was it recovered:
Expand to all the drugs that have ingredients of trimethoprim:
Common drugs associated with Staring:
All the drugs that are associated with Staring:
- Staring (792 drugs)
Common conditions associated with Staring:
- Depression: 182 reports
All the conditions that are associated with Staring:
- Staring (483 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on trimethoprim (the active ingredients of Trimethoprim) and Trimethoprim (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.